Radius Health (RDUS) Tops Q4 EPS by 19c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Radius Health, Inc.: Fourth Quarter and Full Year Results
February 25, 2021 7:00 AM ESTFull year 2020 TYMLOS® U.S. net sales of $208 million was year-over-year growth of 20%Q4 2020 TYMLOS U.S. net sales: $60 million was 8% growth vs. Q4 2019 and 19% growth vs. Q3 2020New patient starts: increased by 26% in Q4 2020 vs. Q3 2020ATOM, wearABLe and EMERALD studies: on schedule for 2H 2021 read-outsJapan regulatory process: remains on trackRAD011 asset integration and forward progress... More
